← All trials
NCT03790085
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2018
- Primary completion
- Jun 30, 2020
- Completion date
- Dec 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 2700
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tianjin Medical UniversityLead sponsor
- Chongqing Medical UniversityCollaborator
- Harbin Medical UniversityCollaborator
- Tianjin Medical UniversityOverall official - principal investigator
- Tianjin Medical UniversityReponsible party - principal investigator
- Jiao Tong UniversityCollaborator
- Tianjin Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Wuhan Psychiatric HospitalCollaborator
- Wenzhou Medical UniversityCollaborator
- the First Specialized Subject Hospital of HarbinCollaborator
- Anhui Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.